Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Recruiting · NCT07495852 · Interventional (participants receive a specific treatment) · Lead sponsor: Glaukos Corporation
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of Ocular Hypertension or Open-Angle Glaucoma in the study eye
Exclusion criteria
- Prior incisional glaucoma surgery in the study eye
- Prior argon laser trabeculoplasty (ALT) in the study eye
- Prior minimally invasive glaucoma (MIGS) surgery in the study eye
Where it is running
1 location listed across 1 US state.
- Glaukos Investigative Site - Dothan, Alabama, United States